Martha Alexander-Miller to Antibodies, Viral
This is a "connection" page, showing publications Martha Alexander-Miller has written about Antibodies, Viral.
Connection Strength
2.603
-
Crofts KF, Holbrook BC, Page CL, Gillespie RA, D'Agostino RB, Sangesland M, Ornelles DA, Kanekiyo M, Alexander-Miller MA. Antibody function predicts viral control in newborn monkeys immunised with an influenza virus HA stem nanoparticle. Nat Commun. 2025 Apr 22; 16(1):3785.
Score: 0.896
-
Holbrook BC, Hayward SL, Blevins LK, Kock N, Aycock T, Parks GD, Alexander-Miller MA. Nonhuman primate infants have an impaired respiratory but not systemic IgG antibody response following influenza virus infection. Virology. 2015 Feb; 476:124-133.
Score: 0.438
-
Zuber MJ, Stamilio DM, Holbrook BC, Snively BM, Jensen ET, Alexander-Miller MA. Maternal influenza vaccination preferentially boosts hemagglutinin stem-specific antibody resulting in efficient transplacental transfer of stem-specific IgG. Int J Gynaecol Obstet. 2023 Jul; 162(1):163-168.
Score: 0.192
-
Williamson JC, Wierzba TF, Santacatterina M, Munawar I, Seals AL, Pittman Ballard CA, Alexander-Miller M, Runyon MS, McCurdy LH, Gibbs MA, Ahmed A, Lagarde WH, Maguire PD, King-Thiele R, Hamrick T, Ihmeidan A, Henderson S, Gallaher TR, Uschner D, Edelstein SL, Herrington DM, Sanders JW. Analysis of accumulated SARS-CoV-2 seroconversion in North Carolina: The COVID-19 Community Research Partnership. PLoS One. 2022; 17(3):e0260574.
Score: 0.181
-
Shultz PK, Crofts KF, Holbrook BC, Alexander-Miller MA. Neuraminidase-specific antibody responses are generated in naive and vaccinated newborn nonhuman primates following virus infection. JCI Insight. 2020 12 17; 5(24).
Score: 0.166
-
Holbrook BC, Aycock ST, Machiele E, Clemens E, Gries D, Jorgensen MJ, Hadimani MB, King SB, Alexander-Miller MA. An R848 adjuvanted influenza vaccine promotes early activation of B cells in the draining lymph nodes of non-human primate neonates. Immunology. 2018 03; 153(3):357-367.
Score: 0.133
-
Holbrook BC, D'Agostino RB, Tyler Aycock S, Jorgensen MJ, Hadimani MB, Bruce King S, Alexander-Miller MA. Adjuvanting an inactivated influenza vaccine with conjugated R848 improves the level of antibody present at 6months in a nonhuman primate neonate model. Vaccine. 2017 10 27; 35(45):6137-6142.
Score: 0.133
-
Holbrook BC, D'Agostino RB, Parks GD, Alexander-Miller MA. Adjuvanting an inactivated influenza vaccine with flagellin improves the function and quantity of the long-term antibody response in a nonhuman primate neonate model. Vaccine. 2016 09 07; 34(39):4712-4717.
Score: 0.123
-
Holbrook BC, Kim JR, Blevins LK, Jorgensen MJ, Kock ND, D'Agostino RB, Aycock ST, Hadimani MB, King SB, Parks GD, Alexander-Miller MA. A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model. J Immunol. 2016 07 15; 197(2):555-64.
Score: 0.121
-
Kim JR, Holbrook BC, Hayward SL, Blevins LK, Jorgensen MJ, Kock ND, De Paris K, D'Agostino RB, Aycock ST, Mizel SB, Parks GD, Alexander-Miller MA. Inclusion of Flagellin during Vaccination against Influenza Enhances Recall Responses in Nonhuman Primate Neonates. J Virol. 2015 Jul; 89(14):7291-303.
Score: 0.112
-
Alexander-Miller MA. Vaccines against respiratory viral pathogens for use in neonates: opportunities and challenges. J Immunol. 2014 Dec 01; 193(11):5363-9.
Score: 0.109